Long Focus Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.69M | Hold |
|
|||||
|
2025
Q1 | $4.68M | Buy |
|
|||||
|
2024
Q4 | $11M | Buy |
|
|||||
|
2024
Q3 | $12.6M | Buy |
|
|||||
|
2024
Q2 | $12M | Buy |
|
|||||
|
2024
Q1 | $16.9M | Sell |
|
|||||
|
2023
Q4 | $9.58M | Buy |
|
|||||
|
2023
Q3 | $8.55M | Buy |
|
|||||
|
2023
Q2 | $7.23M | Buy |
|
|||||
|
2023
Q1 | $5.92M | Buy |
|
|||||
|
2022
Q4 | $7.71M | Buy |
|
|||||
|
2022
Q3 | $5.15M | Buy |
|
|||||
|
2022
Q2 | $7.96M | Buy |
|
|||||
|
2022
Q1 | $9.13M | Buy |
|
|||||
|
2021
Q4 | $8.11M | Buy |
|